The First Mechanical Circulation Auxiliary Forum (MCSS)
Debut in Suzhou
On October 28th and 29th, Dr. Xu Boling, a national youth "Thousand Talents Plan" expert, Distinguished Professor of Suzhou University, founder of Suzhou Xinqing Medical, and hosted by Suzhou University, TEDA International Cardiovascular Hospital and Beijing Precision Electromechanical Control Equipment The first Mechanical Circulation Auxiliary Forum co-sponsored by the Institute was successfully held in Suzhou. Special guest of the forum, the leader of the first forum-Professor Liu Xiaocheng, president of TEDA International Cardiovascular Hospital, Richard Wampler, father of contemporary artificial heart, director of Institute of Cardiovascular Engineering, Aachen University of Technology, Germany, and medical engineering innovation at Monash University, Australia The director of the center, Professor Ulrich Steinseifer, and experts and scholars from academia, industry, and clinical medicine at home and abroad exchanged experience in the research and development, translation, and clinical application of cutting-edge technology assisted by mechanical circulation, and discussed possible modes of international cooperation in the future.
On behalf of the organizing committee, Dr. Xu Boling expressed his welcome and gratitude to the participants: "Mechanical circulation assistance is an extremely subdivided field of medical engineering. The professional span is large and the technical threshold is high, but the application results in this field have great social significance. And clinical value. With the strong support of the state, China has undergone more than 20 years of independent research and development and industrialization. This year, two products have entered the clinical trial stage in succession, and many products have entered the pre-clinical experimental stage, making gratifying progress. We believe that we can stimulate the spark of innovation through open and healthy communication, and let this spark light the lives of patients together. "Then, Professor Sun Lining, Dean of the School of Mechanical and Electrical Engineering of Suzhou University, National Jieqing winner, and the affiliate of Suzhou University Professor Shen Zhenya, Director of Cardiovascular Surgery Department of the First Hospital and Director of the Institute of Cardiovascular Diseases, also expressed congratulations on the forum. Professor Shen Zhenya said cordially that clinicians are eager to get good tools to save patients 'lives. Therefore, as representatives of "important customers", doctors' demand for mechanical circulation assisting technology is urgent.
With the theme of "embrace the possibilities", this forum will carry out in-depth exchanges on the research and development opportunities of artificial heart cutting-edge technologies and the challenges in clinical applications, and hope to open communication channels to jointly promote growth and discover opportunities. This desire is not only supported by international experts, but also by the enthusiastic participation of domestic counterparts. The participants included all experts and scholars who are currently working on artificial heart technology and are interested in artificial heart research in China. Next year, the forum will meet you in Tianjin.
The partners of Suzhou Xinqing Medical also participated in this forum enthusiastically
Guoqian Venture Capital focuses on medical-related industries. Among them, mechanical circulation assists subdivision fields, covering machinery, electronics, materials, engineering, and medical professions. It belongs to high-tech and high value-added industries, and has obvious role in promoting upstream and downstream industries. China has always been at a disadvantage in the field of high-end medical machinery. The development of mechanical circulation assistance is an opportunity for China's industrial upgrading and is also in line with the country's direction of encouraging innovation. We will promote the development of innovative technologies through the support of high-tech projects in this field, especially the research and development of localized medical equipment, and ultimately meet the urgent needs of our patients.
Guoqian Venture Capital is proud to be able to support companies like Suzhou Xinqing Medical. We are convinced that through their unremitting efforts, they will bring effective treatment to patients with severe heart failure and bring dawn to the lives of patients.